Silicon Valley / San Jose Business Journal
Date: Tuesday, May 31, 2011, 2:40pm PDT
Maxygen Inc.bizWatch said Tuesday it plans to repurchase up to $10 million of its common stock through the end of the year.
Since December 2009, Redwood City-based Maxygen (NASDAQ:MAXY) has bought back about 10 million shares for about $54.1 million.
Last month Maxygen received $76 million in cash from Astellas Bio Inc. for the purchase of Maxygen’s equity interests in Perseid Therapeutics LLC, a former majority-owned subsidiary of Maxygen.
Maxygen also remains eligible for a payment of up to $30 million from Bayer HealthCare LLC related to the sale of hematology assets to Bayer in July 2008
FEATURED Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • Oct 1, 2024 8:30 AM
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • Oct 1, 2024 7:00 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM
BARRON'S COVE to Premier at the Hamptons International Film Festival • APHP • Sep 30, 2024 2:56 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM